A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D008920:Misonidazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D009325:Nausea / Q000139:chemically induced; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism; D014839:Vomiting / Q000139:chemically induced
D011838:Radiation-Sensitizing Agents; C041712:1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol; D008920:Misonidazole